KRT17 Promotes the Activation of HSCs Via EMT in Liver Fibrosis

Overview

Journal J Clin Transl Hepatol

Specialty Gastroenterology

Date 2022 May 9

PMID 35528988

Authors

Jing Chen

Si-Jia Ge

Hai-Juan Feng

Shu-Zhen Wu

Ran Ji

Wei-Rong Huang

Wei Huang

Cui-Hua Lu

Affiliations

Soon will be listed here.

Abstract

Background And Aims: Although activation of hepatic stellate cells (HSCs) plays a central role in the development of liver fibrosis, the mechanism underlying the activation of HSCs remains unclear. Keratin 17 (KRT17), a member of the intermediate filament family, can regulate tumor cell proliferation and migration. The current study aimed to elucidate the role of KRT17 in the activation of HSCs and the mechanisms underlying liver fibrosis.

Methods: The expression of KRT17 was determined using immunohistochemistry in tissue microarray. Western blotting and qRT-PCR assays were used to determine the KRT17 expression in fibrotic liver tissues obtained from human subjects and mice. LX-2 cells were treated with TGF-β1 recombinant protein and adipocyte differentiation mixture (MDI) mix to induce and reverse LX-2 cell activation, respectively, in order to explore the correlation between KRT17 and HSC activation. Additionally, cell proliferation and migration abilities of LX-2 cells transfected with KRT17-overexpressing plasmid or small interfering RNA were determined using CCK-8, flow cytometry, Transwell, and wound healing assays. Finally, rescue assay was used to explore the role of KRT17 in HSC activation and epithelial-mesenchymal transition (EMT).

Results: The expression of KRT17 was higher in the human and mouse fibrotic liver tissues than in healthy liver tissues, and it was positively correlated with HSC activation. Upregulated KRT17 enhanced proliferation, migration, HSC activation and EMT in LX-2 cells, while knockdown of KRT17 reversed these effects. TGF-β1 recombinant protein accelerated KRT17-mediated EMT, HSC activation and proliferation, while TGF-β1 inhibitor counteracted the effect of KRT17 .

Conclusions: KRT17 promoted HSC activation, proliferation and EMT in hepatic fibrosis probably via TGF-β1 signaling, and KRT17 might serve as a therapeutic target for the treatment of liver fibrosis.

Citing Articles

Oxidative Stress and Annexin A2 Differential Expression in Free Fatty Acids-Induced Non-Alcoholic Fatty Liver Disease in HepG2 Cells.

Arruda V, Azevedo G, Granato M, Matos A, Araujo T, Guerra J Int J Mol Sci. 2024; 25(17).

PMID: 39273539 PMC: 11395542. DOI: 10.3390/ijms25179591.

CHEK2 knockout is a therapeutic target for TP53-mutated hepatocellular carcinoma.

Chen Y, Zhu Z, Wu X, Li H, Guan W, Ren H Cell Death Discov. 2024; 10(1):37.

PMID: 38242891 PMC: 10799024. DOI: 10.1038/s41420-023-01777-4.

Human liver tissue transcriptomics revealed immunometabolic disturbances and related biomarkers in hepatitis B virus-related acute-on-chronic liver failure.

Yang L, Zhen L, Li Z, Zhu S, Xu W, Luo Q Front Microbiol. 2022; 13:1080484.

PMID: 36532504 PMC: 9752073. DOI: 10.3389/fmicb.2022.1080484.

Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer.

Ding J, Xiao Y, Zhao S, Xu Y, Xiao Y, Shao Z Mol Ther Oncolytics. 2022; 24:624-635.

PMID: 35284626 PMC: 8898759. DOI: 10.1016/j.omto.2022.02.003.

References

Monga S . β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis. Gastroenterology. 2015; 148(7):1294-310. PMC: 4494085. DOI: 10.1053/j.gastro.2015.02.056. View

Mederacke I, Hsu C, Troeger J, Huebener P, Mu X, Dapito D . Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun. 2013; 4:2823. PMC: 4059406. DOI: 10.1038/ncomms3823. View

Pinzani M . Epithelial-mesenchymal transition in chronic liver disease: fibrogenesis or escape from death?. J Hepatol. 2011; 55(2):459-65. DOI: 10.1016/j.jhep.2011.02.001. View

Ding Z, Jin G, Liang H, Wang W, Chen W, Datta P . Transforming growth factor β induces expression of connective tissue growth factor in hepatic progenitor cells through Smad independent signaling. Cell Signal. 2013; 25(10):1981-92. DOI: 10.1016/j.cellsig.2013.05.027. View

Wang Z, Yang M, Lei L, Fei L, Zheng Y, Huang W . Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis. Cancer Manag Res. 2019; 11:7485-7497. PMC: 6689799. DOI: 10.2147/CMAR.S218926. View

Bataller R, Brenner D . Liver fibrosis. J Clin Invest. 2005; 115(2):209-18. PMC: 546435. DOI: 10.1172/JCI24282. View

McGowan K, Coulombe P . Onset of keratin 17 expression coincides with the definition of major epithelial lineages during skin development. J Cell Biol. 1998; 143(2):469-86. PMC: 2132846. DOI: 10.1083/jcb.143.2.469. View

Pellicoro A, Ramachandran P, Iredale J, Fallowfield J . Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol. 2014; 14(3):181-94. DOI: 10.1038/nri3623. View

Nitta T, Kim J, Mohuczy D, Behrns K . Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways. Hepatology. 2008; 48(3):909-19. PMC: 4118693. DOI: 10.1002/hep.22397. View

10.

Moll R, Divo M, Langbein L . The human keratins: biology and pathology. Histochem Cell Biol. 2008; 129(6):705-33. PMC: 2386534. DOI: 10.1007/s00418-008-0435-6. View

11.

Kim S, Wong P, Coulombe P . A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth. Nature. 2006; 441(7091):362-5. DOI: 10.1038/nature04659. View

12.

Carthy J . TGFβ signaling and the control of myofibroblast differentiation: Implications for chronic inflammatory disorders. J Cell Physiol. 2017; 233(1):98-106. DOI: 10.1002/jcp.25879. View

13.

Lee Y, Wallace M, Friedman S . Pathobiology of liver fibrosis: a translational success story. Gut. 2015; 64(5):830-41. PMC: 4477794. DOI: 10.1136/gutjnl-2014-306842. View

14.

Zavadil J, Bottinger E . TGF-beta and epithelial-to-mesenchymal transitions. Oncogene. 2005; 24(37):5764-74. DOI: 10.1038/sj.onc.1208927. View

15.

Ge W, Wang Y, Wu J, Fan J, Chen Y, Zhu L . β-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/β-catenin signaling inhibits hepatic stellate cell activation. Mol Med Rep. 2014; 9(6):2145-51. PMC: 4055486. DOI: 10.3892/mmr.2014.2099. View

16.

Friedman S . Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008; 134(6):1655-69. PMC: 2888539. DOI: 10.1053/j.gastro.2008.03.003. View

17.

Kisseleva T, Brenner D . Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol. 2007; 22 Suppl 1:S73-8. DOI: 10.1111/j.1440-1746.2006.04658.x. View

18.

Ellis E, Mann D . Clinical evidence for the regression of liver fibrosis. J Hepatol. 2012; 56(5):1171-1180. DOI: 10.1016/j.jhep.2011.09.024. View

19.

Kisseleva T, Brenner D . Hepatic stellate cells and the reversal of fibrosis. J Gastroenterol Hepatol. 2006; 21 Suppl 3:S84-7. DOI: 10.1111/j.1440-1746.2006.04584.x. View

20.

Jacob J, Coulombe P, Kwan R, Omary M . Types I and II Keratin Intermediate Filaments. Cold Spring Harb Perspect Biol. 2018; 10(4). PMC: 5880164. DOI: 10.1101/cshperspect.a018275. View